AppFolio's Q4 2024 earnings report highlights the company's robust revenue growth and strategic advancements, though the EPS ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Stock analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for ACADIA Pharmaceuticals in a research report ...
CEO Damian Kozlowski reported Q4 EPS of $1.15 and full-year EPS of $4.29, reflecting year-over-year increases of 41% and 23%, respectively. Total revenue increased 8%, excluding $19.6 million of ...
Inc. reported its fourth-quarter 2024 earnings, revealing a slight miss on earnings per share (EPS) forecasts, which led to a ...
Hess reported strong financial performance in its latest earnings release, driven by production increases in key assets ...
Reports Q4 revenue $205.18M, consensus $202.75M ... expanding operating profit margins, robust EPS growth and record cash flow from operations. We utilized our strong balance sheet and cash ...
Revenue only grew 2 percent year over year for Tesla in Q4 2024.
Novartis reported strong Q4 earnings and sales growth, with CEO Narasimhan reportedly downplaying concerns over Entresto's ...
Total assets were $23.8 billion at December 31, 2024 and September 30, 2024. The tier 1 leverage, common equity tier 1 and total capital ratios were 9.14%, 12.80% and 13.99%, respectively, on ...
AbbVie reported strong Q4 results, driven by Skyrizi, Rinvoq, neuroscience products, and eye care. Click here to find out why ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback